No Market Stabilization or Manipulation. The Company has not taken, and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 4 contracts
Samples: Underwriting Agreement (OptimizeRx Corp), Underwriting Agreement (OptimizeRx Corp), Underwriting Agreement (OptimizeRx Corp)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the 1933 Act which have not been so disclosed in the Registration Statement.
Appears in 3 contracts
Samples: Underwriting Agreement (Abacus Life, Inc.), Underwriting Agreement (Abacus Life, Inc.), Underwriting Agreement (Abacus Life, Inc.)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Securities Act which have not been so disclosed in the Registration Statement.
Appears in 3 contracts
Samples: Purchase Agreement (S&W Seed Co), Purchase Agreement (Endologix Inc /De/), Purchase Agreement (Galena Biopharma, Inc.)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might would reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K S‑K under the Act which have not been so disclosed in the Registration Statement.
Appears in 3 contracts
Samples: Underwriting Agreement (Agilysys Inc), Underwriting Agreement (Bridgepoint Education Inc), Underwriting Agreement (Bridgepoint Education Inc)
No Market Stabilization or Manipulation. The Neither the Company nor the Subsidiary has not taken, and taken or will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company or the Subsidiary to facilitate the sale or resale of the Securities, and or has not effected any sales of Class A Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 3 contracts
Samples: Purchase Agreement (Habit Restaurants, Inc.), Purchase Agreement (Habit Restaurants, Inc.), Form of Purchase Agreement (Habit Restaurants, Inc.)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock Ordinary Shares which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 2 contracts
Samples: Underwriting Agreement (Nyxoah SA), Purchase Agreement (Nyxoah SA)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock Shares which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 2 contracts
Samples: Underwriting Agreement (DiaMedica Therapeutics Inc.), Underwriting Agreement (DiaMedica Therapeutics Inc.)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Securities Act which have not been so disclosed in the Registration Statement.
Appears in 2 contracts
Samples: Underwriting Agreement (HyreCar Inc.), Underwriting Agreement (Allied Esports Entertainment, Inc.)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might would reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, Securities and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 2 contracts
Samples: Purchase Agreement (Valeritas Holdings Inc.), Purchase Agreement (Valeritas Inc)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock securities which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 2 contracts
Samples: Purchase Agreement (Moko Social Media LTD), Purchase Agreement (Moko Social Media LTD)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constitutedconstitutes, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which that are required to be disclosed in response to Item 701 of Regulation S-K under the Act which and that have not been so disclosed in the Registration Statement.
Appears in 2 contracts
Samples: Registration Rights Agreement (Spring Bank Pharmaceuticals, Inc.), Underwriting Agreement (Spring Bank Pharmaceuticals, Inc.)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might would reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the SecuritiesSecurities or the Warrant Shares, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the SecuritiesShares, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might would reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock securities which are required to be disclosed in response to Item 701 of Regulation S-K under the Securities Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might would reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock Shares which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
Samples: Underwriting Agreement (TCP International Holdings Ltd.)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constitutedconstitutes, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which that are required to be disclosed in response to Item 701 of Regulation S-K S‑K under the Act which and that have not been so disclosed in the Registration Statement.
Appears in 1 contract
Samples: Underwriting Agreement (Spring Bank Pharmaceuticals, Inc.)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might would reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K S‑K under the Securities Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might would reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the SecuritiesShares, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Securities Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, Securities and has not effected any sales of shares of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
Samples: Underwriting Agreement (Connexa Sports Technologies Inc.)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which that are required to be disclosed in response to Item 701 of Regulation S-K under the Act which and that have not been so disclosed in the Registration Statement.
Appears in 1 contract
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected affected any sales of Common Stock Ordinary Shares which are required to be disclosed in response to Item 701 of Regulation S-K under the Securities Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might would reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which that are required to be disclosed in response to Item 701 of Regulation S-K under the Act which that have not been so disclosed in the Registration Statement.
Appears in 1 contract
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected affected any sales of Common Stock ADSs or Ordinary Shares which are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
Samples: Purchase Agreement (MDxHealth SA)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected affected any sales of Common Stock ADSs or Ordinary Shares which are required to be disclosed in response to Item 701 of Regulation S-K under the Securities Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
No Market Stabilization or Manipulation. The Company has not taken, and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K under the Securities Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
Samples: Purchase Agreement (Neogenomics Inc)
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which are required to be disclosed in response to Item 701 of Regulation S-K SK under the Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
No Market Stabilization or Manipulation. The Company has not taken, taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which that are required to be disclosed in response to Item 701 of Regulation S-K under the Act which have not been so disclosed in the Registration Statement.
Appears in 1 contract
